GRIN2A and Behcet disease: Our observation of increased GABAAα1 expression suggests that BD treatment may further reduce visually evoked activity in the V1 that is compounded by the shift to more GluN2A reducing the availability of the NMDA-dependent mechanism needed to consolidate visual recovery.